Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | S15 - Aging and Dementia 1

Monday 04/04/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Sudha Seshadri, MD, FAAN, Suman Jayadev, MD
Aging, Dementia, and Behavioral Neurology
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:30 PM PDT Speaker walk in slides
Erin Jackson
03:30 PM - 03:42 PM PDT Abstract 001 - Psychosis in Neurodegenerative Disease
Andrew Breithaupt, MD
03:42 PM - 03:54 PM PDT Abstract 002 - Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of Amyotrophic Lateral Sclerosis.
Myrna Dominique
03:54 PM - 04:06 PM PDT Abstract 003 - African Locus Reduces the Effect of ApoE e4 Allele in Alzheimer’s Disease
Farid Rajabli, PhD
04:06 PM - 04:18 PM PDT Abstract 004 - Belgian Carriers of Rare ABCA7 Mutations Present with Pronounced Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Elisabeth Hendrickx Van de Craen, MD
04:18 PM - 04:30 PM PDT Abstract 005 - Prevalence and Location of White Matter Hyperintensities in Traumatic Brain Injury and Relationship to Outcome
Abbie Chan
04:30 PM - 04:42 PM PDT Abstract 006 - Association of the Mediterranean Diet and Cognition Function among Hispanics/Latinos
Gabriela Trifan, MD
04:42 PM - 04:54 PM PDT Abstract 007 - Evaluation of Intensive Versus Standard Blood Pressure Reduction and Association with Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis
Caroline Dallaire-Théroux, MD, PhD
04:54 PM - 05:06 PM PDT Abstract 008 - Cardiorespiratory Fitness Is Protective Against Alzheimer's and Related Disorders
Edward Y. Zamrini, MD
05:06 PM - 05:18 PM PDT Abstract 009 - A Retrospective Study of Androgen Targeting Therapies and Incidence of Neurodegenerative Outcomes in Male Prostate Cancer Patients: Implications for Clinic to Bench Translation
Gregory L. Branigan, PhD
05:18 PM - 05:30 PM PDT Abstract 010 - Statin Responder Analysis for Precision Prevention of Neurological Diseases
Georgina Torrandell Haro
Faculty Disclosures
Anthony J. Griswold, PhD Dr. Griswold has received research support from National Institutes of Health.
No disclosure on file
Simon Duchesne, PhD Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care.
Derek Dykxhoorn, PhD No disclosure on file
Gabriela Trifan, MD Dr. Trifan has nothing to disclose.
Abbie Chan Miss Chan has nothing to disclose.
Jeffery M. Vance, MD, PhD Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Peter P. De Deyn, MD, PhD Dr. De Deyn has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier.
James J. Gugger, Jr., MD, PharmD Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Briseida E. Feliciano Astacio, MD, FAAN Dr. Feliciano Astacio has received research support from NIA/NIH.
Marie-Christine Camden, MD Dr. Camden has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Myrna Dominique Miss Dominique has nothing to disclose.
Carmen Isasi No disclosure on file
Georgina Torrandell Haro Miss Torrandell Haro has nothing to disclose.
Gary W. Beecham, PhD The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Anne Sieben, MD Dr. Sieben has nothing to disclose.
Ali Ahmed No disclosure on file
Jonathan Haines, MD No disclosure on file
Lea Grinberg Lea Grinberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Inc. The institution of Lea Grinberg has received research support from NIH. The institution of Lea Grinberg has received research support from Eli Lilly. The institution of Lea Grinberg has received research support from BrightFouus. The institution of Lea Grinberg has received research support from Rainwater Charity Foundation.
Patrick Cras, MD, PhD The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee.
Steve Verreault, MD The institution of Dr. Verreault has received research support from BMS. The institution of Dr. Verreault has received research support from Portola. The institution of Dr. Verreault has received research support from Daichii Sankyo.
Peter Kokkinos No disclosure on file
Elisabeth Hendrickx Van de Craen, MD Dr. Hendrickx Van de Craen has nothing to disclose.
Edward Y. Zamrini, MD Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Karen Nuytemans, PhD The institution of Dr. Nuytemans has received research support from NIH. The institution of Dr. Nuytemans has received research support from NIH. The institution of Dr. Nuytemans has received research support from Department of Defense. The institution of Dr. Nuytemans has received research support from Margaret Q. Landenberger Foundation. The institution of Dr. Nuytemans has received research support from American Parkinson Disease Association. The institution of Dr. Nuytemans has received research support from Florida Department of Health.
Salvatore Spina, MD Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acsel Health. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Xtract. Dr. Spina has received research support from Tau Consortium. Dr. Spina has received research support from Chan Zuckerberg Initiative, LLC. Dr. Spina has received research support from Bluefield Project to Cure FTD.
Fernando D. Testai, MD, PhD, FAAN Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Swanson Martin & Bell, LLP. Dr. Testai has received publishing royalties from a publication relating to health care.
Wassim Tarraf No disclosure on file
Qing Zeng-Treitler No disclosure on file
Ariana Stickel No disclosure on file
William Seeley, MD Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Georges Naasan, MD Dr. Naasan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech .
Caroline Dallaire-Théroux, MD, PhD Dr. Dallaire-Théroux has received research support from Canadian Institutes of Health Research (CIHR).
Karine Brochu, MD Dr. Brochu has nothing to disclose.
Hector Gonzalez No disclosure on file
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Bayan Moustafa, DO Dr. Moustafa has nothing to disclose.
Robert Laforce, Jr., MD, PhD Dr. Laforce has nothing to disclose.
Marie-Hélène Quesnel-Olivo, MD Dr. Quesnel-Olivo has nothing to disclose.
Gregory L. Branigan, PhD Dr. Branigan has nothing to disclose.
Adesola Ogunniyi, MD Dr. Ogunniyi has nothing to disclose.
Andrew Breithaupt, MD Dr. Breithaupt has nothing to disclose.
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Estrella Morenas Rodriguez, MD No disclosure on file
Yan Cheng No disclosure on file
Jianwen Cai No disclosure on file
Gregory Talavera No disclosure on file
Martha Daviglus No disclosure on file
Anna Karydas No disclosure on file
Farid Rajabli, PhD Farid Rajabli has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ischemix, Inc. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pinteon Therapeutics. Dr. Diaz-Arrastia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from BrainBox, LLC. Dr. Diaz-Arrastia has received stock or an ownership interest from NovaSignal . Dr. Diaz-Arrastia has received stock or an ownership interest from Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Roberta Diaz Brinton, PhD Roberta Diaz Brinton, PhD has nothing to disclose.
Yijun Shao No disclosure on file
Sebastiaan Engelborghs, MD, PhD No disclosure on file
Helen Sheriff No disclosure on file
Christiane Reitz, MD, PhD No disclosure on file
Christine Van Broeckhoven, PhD Dr. Van Broeckhoven has nothing to disclose.
Sudha Seshadri, MD, FAAN Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Suman Jayadev, MD Dr. Jayadev has nothing to disclose.
Erin Jackson Ms. Jackson has nothing to disclose.